Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate

References

• Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, . Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005; 7:393–5.
   PubMed Web of Science ®Google Scholar
• Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol. 2004;36:568–84.
   PubMed Web of Science ®Google Scholar
• Garcia-Gomez I, Elvira G, Zapata AG, Lamana ML, Ramirez M, Castro JG, . Mesenchymal stem cells: biological properties and clinical applications. Expert Opin Biol Ther. 2010;10:1453–68.
   PubMed Web of Science ®Google Scholar
• Garcia-Olmo D, Garcia-Arranz M, Herreros D, Pascual I, Peiro C, Rodriguez-Montes JA. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum. 2005;48:1416–23.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, . Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371:1579–86.
   PubMed Web of Science ®Google Scholar
• Sensebe L, Bourin P. Mesenchymal stem cells for therapeutic purposes. Transplantation. 2009;87:S49–53.
   PubMedGoogle Scholar
• Wu KH, Zhou B, Yu CT, Cui B, Lu SH, Han ZC, . Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model. Ann Thorac Surg. 2007;83:1491–8.
   PubMed Web of Science ®Google Scholar
• Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells. 2007;25:1384–92.
   PubMed Web of Science ®Google Scholar
• Fan CG, Zhang QJ, Zhou JR. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev. 2010;7(1):195–207.
   Google Scholar
• Can A, Karahuseyinoglu S. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells. 2007;25:2886–95.
   PubMed Web of Science ®Google Scholar
• Majore I, Moretti P, Stahl F, Hass R, Kasper C. Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord. Stem Cell Rev. 2011;7:17–31.
   Google Scholar
• Troyer DL, Weiss ML. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells. 2008;26:591–9.
   PubMed Web of Science ®Google Scholar
• Weiss ML, Troyer DL. Stem cells in the umbilical cord. Stem Cell Rev. 2006;2:155–62.
   PubMed Web of Science ®Google Scholar
• Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, . Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells. 2006;24:781–92.
   PubMed Web of Science ®Google Scholar
• Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells. 2005;23:220–9.
   PubMed Web of Science ®Google Scholar
• Sarugaser R, Ennis J, Stanford WL, Davies JE. Isolation, propagation, and characterization of human umbilical cord perivascular cells (HUCPVCs). Methods Mol Biol. 2009;482: 269–79.
   PubMedGoogle Scholar
• Covas DT, Siufi JL, Silva AR, Orellana MD. Isolation and culture of umbilical vein mesenchymal stem cells. Braz J Med Biol Res. 2003;36:1179–83.
   PubMed Web of Science ®Google Scholar
• Jomura S, Uy M, Mitchell K, Dallasen R, Bode CJ, Xu Y. Potential treatment of cerebral global ischemia with Oct-4+ umbilical cord matrix cells. Stem Cells. 2007;25:98–106.
   PubMed Web of Science ®Google Scholar
• Lund RD, Wang S, Lu B, Girman S, Holmes T, Sauve Y, . Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells. 2007;25:602–11.
   PubMed Web of Science ®Google Scholar
• Mitchell KE, Weiss ML, Mitchell BM, Martin P, Davis D, Morales L, . Matrix cells from Wharton's jelly form neurons and glia. Stem Cells. 2003;21:50–60.
   PubMed Web of Science ®Google Scholar
• Capelli C, Domenghini M, Borleri G, Bellavita P, Poma R, Carobbio A, . Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplant. 2007;40:785–91.
   PubMed Web of Science ®Google Scholar
• Capelli C, Salvade A, Pedrini O, Barbui V, Gotti E, Borleri G, . The washouts of discarded bone marrow collection bags and filters are a very abundant source of hMSCs. Cytotherapy. 2009;11:403–13.
   PubMed Web of Science ®Google Scholar
• Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E, . Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion. 2007;47:1436–46.
   PubMed Web of Science ®Google Scholar
• Meyer T. Isolation and characterisation of mesenchymal stem cells in Wharton's jelly of the human umbilical cord: potent cells for cell-based therapies in paediatric surgery? Eur Surg. 2008;40:239–44.
   Google Scholar
• Petsa A, Gargani S, Felesakis A, Grigoriadis N, Grigoriadis I. Effectiveness of protocol for the isolation of Wharton's jelly stem cells in large-scale applications. In Vitro Cell Dev Biol Anim. 2009;45(10):573–6.
   Google Scholar
• Schugar RC, Chirieleison SM, Wescoe KE, Schmidt BT, Askew Y, Nance JJ, . High harvest yield, high expansion, and phenotype stability of CD146 mesenchymal stromal cells from whole primitive human umbilical cord tissue. J Biomed Biotechnol. 2009;789526.
   Google Scholar
• Majore I, Moretti P, Hass R, Kasper C. Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. Cell Commun Signal. 2009;7:1–8.
   Google Scholar
• Reinisch A, Strunk D. Isolation and animal serum free expansion of human umbilical cord derived mesenchymal stromal cells (MSCs) and endothelial colony forming progenitor cells (ECFCs). J Vis Exp. 2009;32:1–4.
   Google Scholar
• Leibovitz A, Stinson JC, McCombs WB 3rd, McCoy CE, Mazur KC, Mabry ND. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 1976;36:4562–9.
   PubMed Web of Science ®Google Scholar
• Lyons AB. Divided we stand: tracking cell proliferation with carboxyfluorescein diacetate succinimidyl ester. Immunol Cell Biol. 1999;77:509–15.
   PubMedGoogle Scholar
• Valencic E, Piscianz E, Andolina M, Ventura A, Tommasini A. The immunosuppressive effect of Wharton's jelly stromal cells depends on the timing of their licensing and on lymphocyte activation. Cytotherapy. 2010;12:154–60.
   Web of Science ®Google Scholar
• Runge HM, Neumann HA, Bucke W, Pfleiderer A. Cloning ovarian carcinoma cells in an agar double layer versus a methylcellulose monolayer system. A comparison of two methods. J Cancer Res Clin Oncol. 1985;110:51–5.
   Google Scholar
• Shin SI, Freedman VH, Risser R, Pollack R. Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc Natl Acad Sci USA. 1975;72:4435–9.
   PubMed Web of Science ®Google Scholar
• Chen K, Wang D, Du WT, Han ZB, Ren H, Chi Y, . Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism. Clin Immunol. 2010;135: 448–58.
   Google Scholar
• Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, . An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008;40:499–507.
   PubMed Web of Science ®Google Scholar
• Fong CY, Chak LL, Biswas A, Tan JH, Gauthaman K, Chan WK, . Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev. 2011;7:1–16.
   PubMed Web of Science ®Google Scholar
• Caplan AI. Why are MSCs therapeutic? New data: new insight. J Pathol. 2009;217:318–24.
   PubMed Web of Science ®Google Scholar
• Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, Demiralp DO, . Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells. 2007;25:319–31.
   PubMed Web of Science ®Google Scholar
• Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells. 2003;21:105–10.
   PubMed Web of Science ®Google Scholar
• Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, . Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells. 2004;22:1330–7.
   PubMed Web of Science ®Google Scholar
• Mitchell KE. Umbilical cord stem cells. Lester LB. Contemporary Endocrinology: Stem Cells in Endocrinology. Totowa: Humana Press Inc.; 2003. 49–65.
   Google Scholar
• Fong CY, Richards M, Manasi N, Biswas A, Bongso A. Comparative growth behaviour and characterization of stem cells from human Wharton's jelly. Reprod Biomed Online. 2007;15:708–18.
   PubMed Web of Science ®Google Scholar
• Liao W, Xie J, Zhong J, Liu Y, Du L, Zhou B, . Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation. 2009; 87:350–9.
   PubMed Web of Science ®Google Scholar
• Schallmoser K, Rohde E, Bartmann C, Obenauf AC, Reinisch A, Strunk D. Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells. Biomed Mater Eng. 2009;19:271–6.
   Google Scholar
• Schallmoser K, Rohde E, Reinisch A, Bartmann C, Thaler D, Drexler C, . Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C Methods. 2008;14: 185–96.
   PubMed Web of Science ®Google Scholar
• La Rocca G, Anzalone R, Corrao S, Magno F, Loria T, Lo Iacono M, . Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol. 2009;131:267–82.
   PubMed Web of Science ®Google Scholar
• Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, . Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 2006;91:1017–26.
   PubMed Web of Science ®Google Scholar
• Girdlestone J, Limbani VA, Cutler AJ, Navarrete CV. Efficient expansion of mesenchymal stromal cells from umbilical cord under low serum conditions. Cytotherapy. 2009;11: 738–48.
   PubMed Web of Science ®Google Scholar
• Suzdal'tseva YG, Burunova VV, Vakhrushev IV, Yarygin VN, Yarygin KN. Capability of human mesenchymal cells isolated from different sources to differentiation into tissues of mesodermal origin. Bull Exp Biol Med. 2007;143:114–21.
   Google Scholar
• Prasanna SJ, Gopalakrishnan D, Shankar SR, Vasandan AB. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One. 2010;5:e9016.
   PubMed Web of Science ®Google Scholar
• Schneider RK, Puellen A, Kramann R, Raupach K, Bornemann J, Knuechel R, . The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds. Biomaterials. 2010;31:467–80.
   PubMed Web of Science ®Google Scholar
• Yoo KH, Jang IK, Lee MW, Kim HE, Yang MS, Eom Y, . Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol. 2009;259:150–6.
   PubMed Web of Science ®Google Scholar
• Lucchini G, Introna M, Dander E, Rovelli A, Balduzzi A, Bonanomi S, . Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population. Biol Blood Marrow Transplant. 2009;16:1293–301.
   Google Scholar
• Tisato V, Naresh K, Girdlestone J, Navarrete C, Dazzi F. Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease. Leukemia. 2007;21:1992–9.
   PubMed Web of Science ®Google Scholar
• Morigi M, Rota C, Montemurro T, Montelatici E, Lo Cicero V, Imberti B, . Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Stem Cells. 2010;28:513–22.
   PubMed Web of Science ®Google Scholar
• Fong CY, Subramanian A, Biswas A, Gauthaman K, Srikanth P, Hande MP, . Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton's jelly stem cells. Reprod Biomed Online. 2010;21:391–401.
   Google Scholar
• Tarte K, Gaillard J, Lataillade JJ, Fouillard L, Becker M, Mossafa H, . Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood. 2010;115:1549–53.
   PubMed Web of Science ®Google Scholar